Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With High Bleeding Risk: Insight From the STOPDAPT-2 Trial

Circulation. 2019 Dec 3;140(23):1957-1959. doi: 10.1161/CIRCULATIONAHA.119.043613. Epub 2019 Sep 27.
No abstract available

Keywords: hemorrhage; percutaneous coronary intervention; platelet aggregation inhibitors; stents; thrombosis.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aspirin / administration & dosage
  • Aspirin / adverse effects
  • Aspirin / therapeutic use*
  • Chromium Alloys
  • Clopidogrel / administration & dosage
  • Clopidogrel / adverse effects
  • Clopidogrel / therapeutic use*
  • Coronary Restenosis / epidemiology
  • Coronary Restenosis / etiology
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Drug-Eluting Stents
  • Everolimus / administration & dosage
  • Everolimus / therapeutic use*
  • Female
  • Hemorrhage / chemically induced
  • Hemorrhage / prevention & control*
  • Humans
  • Incidence
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Multicenter Studies as Topic / statistics & numerical data*
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / etiology
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Postoperative Complications / prevention & control
  • Proportional Hazards Models
  • Randomized Controlled Trials as Topic / statistics & numerical data*
  • Single-Blind Method
  • Stroke / epidemiology
  • Stroke / etiology

Substances

  • Chromium Alloys
  • Platelet Aggregation Inhibitors
  • Everolimus
  • Clopidogrel
  • Aspirin